The company has one of the largest stem cell banks in the world-Tianjin Umbilical Cord Blood Hematopoietic Stem Cell Bank, which is the first batch of umbilical cord blood hematopoietic stem cell banks in China (Wei Umbilical Cord Blood Stem Cell Bank Zi [2002] No.002) and the first batch of umbilical cord blood hematopoietic stem cell banks approved by Asian Umbilical Cord Blood Bank, with a daily processing capacity of 100 and a total storage capacity of 300,000. Since it was officially put into operation in April, 20001,it has received more than a thousand matching inquiries at home and abroad, and the probability of finding unrelated donor umbilical cord blood with more than four HLA (human leukocyte antigen) sites for patients reached 93%, and more than 20 cases were successfully transplanted.
The Department of Monoclonal Antibodies and Diagnostic Reagents has made full use of the technical accumulation of the Institute of Hematology, China Academy of Medical Sciences for more than 20 years, and developed a large number of monoclonal antibodies against human T, B, granulocyte/monocyte, platelet, red blood cell, HLA-I and HLA-II haplotypes 100, of which more than 60 kinds 100 strains were recognized by the International Human Differentiation and Clustering Conference (HLDA). In 2004, the project of "Large-scale production of fluorescent labeled domestic CD monoclonal antibodies" funded by the Innovation Fund of Science and Technology SMEs of the Ministry of Science and Technology passed the formal acceptance. Products such as flow cytometry labeling reagents (including lymphocyte subgroup typing kits) have been developed and produced one after another, which meets the needs of flow cytometry users to use domestic high-quality and low-cost direct labeling reagents. "Monovalent Coombs Antibody Diagnostic Kit for Autoimmune Hemolytic Anemia" obtained the new drug certificate (National Medicine Certificate S20030009) issued by the US Food and Drug Administration, and won the national key new product in 2003.
The company's stem cell project was approved by the State Planning Commission as a high-tech industrialization demonstration project of the national stem cell engineering product industrialization base (Ji [2000] 1823). In 2005, it was recognized as a "major high-tech industrialization project in Tianjin" by the Tianjin municipal government, and it has officially passed the acceptance of the project expert group and the environmental protection acceptance after completion.